Results 291 to 300 of about 650,104 (308)

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

Lancet, The, 2010
Johann S de Bono, Stéphane Oudard, Mustafa Ozguroglu   +2 more
exaly  

Sunitinib malate for metastatic castration-resistant prostate cancer following docetaxel-based chemotherapy

Annals of Oncology, 2010
G Sonpavde, D Weckstein, M D Galsky
exaly  

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

Lancet, The, 2011
Michael Carducci, Ronaldo Damiao, Janet E Brown   +2 more
exaly  

Castration-Resistant Prostate Cancer: AUA Guideline Amendment 2015

Journal of Urology, 2016
William T Lowrance, Michael S Cookson
exaly  

<p>Darolutamide For Castration-Resistant Prostate Cancer</p>

OncoTargets and Therapy, 2019
Diogo A Bastos, Emmanuel S Antonarakis
exaly  

Castration-Resistant Prostate Cancer: AUA Guideline Amendment 2018

Journal of Urology, 2018
William T Lowrance, William K Oh, David F Jarrard   +2 more
exaly  

Castration-resistant prostate cancer: latest evidence and therapeutic implications

Therapeutic Advances in Medical Oncology, 2014
Daniel L Suzman, Emmanuel S Antonarakis
exaly  

Castrate-Resistant Prostate Cancer

Oncology Times, 2008
openaire   +2 more sources

lncRNA HOXD-AS1 Regulates Proliferation and Chemo-Resistance of Castration-Resistant Prostate Cancer via Recruiting WDR5

Molecular Therapy, 2017
Peng Gu, Xu Chen, Jinli Han
exaly  

Chemotherapy in patients with castration-resistant prostate cancer

European Journal of Cancer, 2009
Meulenbeld, Hielke, Hamberg, Paul, de Wit, Ronald   +2 more
openaire   +2 more sources